Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert J Ferrante

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Journal of Neurochemistry|June 6, 2003
Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic miceAlpaslan Dedeoglu, James K Kubilus, Lichuan Yang, et al.
Bioorganic & Medicinal Chemistry|December 23, 2011
Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cellsWei Zhang, Radhia Benmohamed, Anthony C Arvanites, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 16, 2010
Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosisRadhia Benmohamed, Anthony C Arvanites, Jinho Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2003
Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neuronsHoon Ryu, Junghee Lee, Khalequz Zaman, et al.
Journal of Neurochemistry|November 19, 2003
Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's diseaseYu Zhang, Victor O Ona, Mingwei Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2002
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's diseaseRobert J Ferrante, Ole A Andreassen, Alpaslan Dedeoglu, et al.
Neuromolecular Medicine|July 4, 2002
Cytochrome C and caspase-9 expression in Huntington's diseaseTamara Kiechle, Alpaslan Dedeoglu, James Kubilus, et al.
Journal of Medicinal Chemistry|March 8, 2011
Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosisGuoyao Xia, Radhia Benmohamed, Jinho Kim, et al.
Neurobiology of Disease|October 12, 2004
Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic miceFran Norflus, Agnes Nanje, Claire-Anne Gutekunst, et al.
Human Molecular Genetics|July 28, 2010
Mitochondrial loss, dysfunction and altered dynamics in Huntington's diseaseJinho Kim, Jennifer P Moody, Christina K Edgerly, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Journal of Neurochemistry|June 6, 2003
Creatine therapy provides neuroprotection after onset of clinical symptoms in Huntington's disease transgenic miceAlpaslan Dedeoglu, James K Kubilus, Lichuan Yang, et al.
Bioorganic & Medicinal Chemistry|December 23, 2011
Cyclohexane 1,3-diones and their inhibition of mutant SOD1-dependent protein aggregation and toxicity in PC12 cellsWei Zhang, Radhia Benmohamed, Anthony C Arvanites, et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases|November 16, 2010
Identification of compounds protective against G93A-SOD1 toxicity for the treatment of amyotrophic lateral sclerosisRadhia Benmohamed, Anthony C Arvanites, Jinho Kim, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 9, 2003
Sp1 and Sp3 are oxidative stress-inducible, antideath transcription factors in cortical neuronsHoon Ryu, Junghee Lee, Khalequz Zaman, et al.
Journal of Neurochemistry|November 19, 2003
Sequential activation of individual caspases, and of alterations in Bcl-2 proapoptotic signals in a mouse model of Huntington's diseaseYu Zhang, Victor O Ona, Mingwei Li, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2002
Therapeutic effects of coenzyme Q10 and remacemide in transgenic mouse models of Huntington's diseaseRobert J Ferrante, Ole A Andreassen, Alpaslan Dedeoglu, et al.
Neuromolecular Medicine|July 4, 2002
Cytochrome C and caspase-9 expression in Huntington's diseaseTamara Kiechle, Alpaslan Dedeoglu, James Kubilus, et al.
Journal of Medicinal Chemistry|March 8, 2011
Pyrimidine-2,4,6-trione derivatives and their inhibition of mutant SOD1-dependent protein aggregation. Toward a treatment for amyotrophic lateral sclerosisGuoyao Xia, Radhia Benmohamed, Jinho Kim, et al.
Neurobiology of Disease|October 12, 2004
Anti-inflammatory treatment with acetylsalicylate or rofecoxib is not neuroprotective in Huntington's disease transgenic miceFran Norflus, Agnes Nanje, Claire-Anne Gutekunst, et al.
Human Molecular Genetics|July 28, 2010
Mitochondrial loss, dysfunction and altered dynamics in Huntington's diseaseJinho Kim, Jennifer P Moody, Christina K Edgerly, et al.
Pageof 9